"A Complaint was unsealed today in U.S. District Court in Massachusetts against a New York pharmaceutical company for alleged False Claims Act violations arising from the company’s marketing the drugs Celexa and Lexapro for unapproved pediatric use and for paying kickbacks to induce physicians to prescribe the drugs." Read the Department of Justice press release here.
The New York Times reports here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment